Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non‑small cell lung cancer treated with erlotinib-Reference-Cited by-同舟云学术

Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non‑small cell lung cancer treated with erlotinib

Published:2020-05-21 Issue:2 Volume:20 Page:1376-1382
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Svaton Martin¹,Fiala Ondrej²,Krakorova Gabriela¹,Blazek Jiri¹,Hurdalkova Karolina³,Barinova Magda³,Mukensnabl Petr⁴,Pesek Milos¹

Affiliation:

1. Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic

2. Department of Oncology and Radiotherapy, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic

3. Institute of Biostatistics and Analyses Ltd., 625 00 Brno, Czech Republic

4. Department of Pathology, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of NKX2-1 as a biomarker for clinical prognosis, immune infiltration, and drug therapy in lung squamous cell carcinoma;PeerJ;2024-05-01

2. Does the Expression of Vascular Endothelial Growth Factor (VEGF) and Bcl-2 Have a Prognostic Significance in Advanced Non-Small Cell Lung Cancer?;Healthcare;2023-01-18

3. Xprediction: Explainable EGFR-TKIs response prediction based on drug sensitivity specific gene networks;PLOS ONE;2022-05-18

4. Immunological aspects of papillary thyroid cancer. What's new?;Clinical and experimental thyroidology;2021-06-15

5. Association between epidermal growth factor receptor mutation status, clinicopathological characteristics and TTF-1 expression in lung adenocarcinoma: A single center study;Srpski arhiv za celokupno lekarstvo;2021